
    failure to recruit
  
['nonalcoholic fatty liver disease (nafld)']
['ez-urso combination therapy']

        Inclusion Criteria:

          -  Steatosis

          -  ALT >1.5 times normal

          -  ALT/AST ratio >1.0

          -  Normal Kidney Function

        Exclusion Criteria:

          -  Normal ALT within last 6 months

          -  Advanced fibrosis based on 1) biopsy, if available (Stage 3 or 4 NAFLD), 2) imaging,
             or 3) lab (platelet count <150,000)

          -  Daily alcohol use above 20 g/day for women and 30 g/day for men

          -  Prescription use of ursodiol, ezetimibe, vitamin E, fish oils, thiazolidinediones,
             insulin, sulfonylureas, HMG-CoA reductase inhibitors

          -  Weight loss greater than 15% in past 12 months

          -  Pregnant or breastfeeding

          -  Body Mass index greater than 50

          -  Largest body circumference greater than 160 cm

          -  Claustrophobia

          -  Allergy to ezetimibe or ursodiol
      